MEI Pharma Inc (MEIP)
2.80
-0.01
(-0.36%)
USD |
NASDAQ |
Nov 22, 09:37
MEI Pharma Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 86.33% |
| June 30, 2023 | -688.3% |
| March 31, 2023 | -261.9% |
| December 31, 2022 | 31.32% |
| September 30, 2022 | -190.4% |
| June 30, 2022 | -140.7% |
| March 31, 2022 | -90.00% |
| December 31, 2021 | -102.7% |
| September 30, 2021 | -225.7% |
| June 30, 2021 | -112.4% |
| March 31, 2021 | -316.0% |
| December 31, 2020 | -63.72% |
| September 30, 2020 | 10.73% |
| June 30, 2020 | -80.64% |
| March 31, 2020 | -348.0% |
| December 31, 2019 | -2.01K% |
| September 30, 2019 | -258.8% |
| June 30, 2019 | |
| March 31, 2019 | -1.39K% |
| December 31, 2018 | |
| September 30, 2018 | -2.98K% |
| June 30, 2018 | -3.51K% |
| March 31, 2018 | -1.37K% |
| December 31, 2017 | -1.70K% |
| September 30, 2017 | -3.11K% |
| Date | Value |
|---|---|
| June 30, 2017 | -967.3% |
| March 31, 2017 | -13.36% |
| December 31, 2016 | 69.10% |
| September 30, 2016 | -389.6% |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.01K%
Minimum
Dec 2019
86.33%
Maximum
Sep 2023
-281.1%
Average
-126.6%
Median
Profit Margin (Quarterly) Benchmarks
| Avid Bioservices Inc | -13.78% |
| Evoke Pharma Inc | -49.45% |
| Revance Therapeutics Inc | -63.65% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |